April 1, 2014
Chief Commercial Officer Eric Pauwels NPS Pharmaceuticals, a US biotech specializing in rare diseases, is gearing up to take a stab at the Japanese market, with the release of its Short Bowel Syndrome drug Gattex (teduglutide) as early as 2017,...read more